• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双重功能趋化因子受体 CCR2 通过不同的机制驱动迁移和趋化因子清除。

The dual-function chemokine receptor CCR2 drives migration and chemokine scavenging through distinct mechanisms.

机构信息

Biomedical Sciences Program, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093, USA.

出版信息

Sci Signal. 2023 Jan 31;16(770):eabo4314. doi: 10.1126/scisignal.abo4314.

DOI:10.1126/scisignal.abo4314
PMID:36719944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10091583/
Abstract

C-C chemokine receptor 2 (CCR2) is a dual-function receptor. Similar to other G protein-coupled chemokine receptors, it promotes monocyte infiltration into tissues in response to the chemokine CCL2, and, like atypical chemokine receptors (ACKRs), it scavenges chemokine from the extracellular environment. CCR2 therefore mediates CCL2-dependent signaling as a G protein-coupled receptor (GPCR) and also limits CCL2 signaling as a scavenger receptor. We investigated the mechanisms underlying CCR2 scavenging, including the involvement of intracellular proteins typically associated with GPCR signaling and internalization. Using CRISPR knockout cell lines, we showed that CCR2 scavenged by constitutively internalizing to remove CCL2 from the extracellular space and recycling back to the cell surface for further rounds of ligand sequestration. This process occurred independently of G proteins, GPCR kinases (GRKs), β-arrestins, and clathrin, which is distinct from other "professional" chemokine scavenger receptors that couple to GRKs, β-arrestins, or both. These findings set the stage for understanding the molecular regulators that determine CCR2 scavenging and may have implications for drug development targeting this therapeutically important receptor.

摘要

C-C 趋化因子受体 2(CCR2)是一种双功能受体。与其他 G 蛋白偶联趋化因子受体类似,它促进单核细胞浸润到组织中,以响应趋化因子 CCL2,并且与非典型趋化因子受体(ACKR)一样,它从细胞外环境中清除趋化因子。因此,CCR2 通过作为 G 蛋白偶联受体(GPCR)介导 CCL2 依赖性信号转导,并且还作为清除受体限制 CCL2 信号转导。我们研究了 CCR2 清除的机制,包括与 GPCR 信号转导和内化相关的细胞内蛋白的参与。使用 CRISPR 敲除细胞系,我们表明 CCR2 通过组成型内化来清除细胞外空间中的 CCL2,并回收回细胞表面以进行进一步的配体隔离,从而清除 CCL2。这个过程独立于 G 蛋白、GPCR 激酶(GRKs)、β-arrestin 和网格蛋白,这与其他与 GRKs、β-arrestin 或两者结合的“专业”趋化因子清除受体不同。这些发现为理解决定 CCR2 清除的分子调节剂奠定了基础,并可能对靶向该治疗上重要受体的药物开发具有意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/c79e86c55bcb/nihms-1879123-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/be9193a2e138/nihms-1879123-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/d58c9079ac96/nihms-1879123-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/a995def4045d/nihms-1879123-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/3df7006aeb1a/nihms-1879123-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/1ec5f31bc4ae/nihms-1879123-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/f073c9ab1da0/nihms-1879123-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/a50dd005c12c/nihms-1879123-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/c79e86c55bcb/nihms-1879123-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/be9193a2e138/nihms-1879123-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/d58c9079ac96/nihms-1879123-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/a995def4045d/nihms-1879123-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/3df7006aeb1a/nihms-1879123-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/1ec5f31bc4ae/nihms-1879123-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/f073c9ab1da0/nihms-1879123-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/a50dd005c12c/nihms-1879123-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/10091583/c79e86c55bcb/nihms-1879123-f0008.jpg

相似文献

1
The dual-function chemokine receptor CCR2 drives migration and chemokine scavenging through distinct mechanisms.双重功能趋化因子受体 CCR2 通过不同的机制驱动迁移和趋化因子清除。
Sci Signal. 2023 Jan 31;16(770):eabo4314. doi: 10.1126/scisignal.abo4314.
2
Characterization of conventional and atypical receptors for the chemokine CCL2 on mouse leukocytes.对小鼠白细胞上趋化因子 CCL2 的常规和非典型受体的特征描述。
J Immunol. 2014 Jul 1;193(1):400-11. doi: 10.4049/jimmunol.1303236. Epub 2014 Jun 2.
3
Gas6 Promotes Inflammatory (CCR2CX3CR1) Monocyte Recruitment in Venous Thrombosis.Gas6促进静脉血栓形成中炎性(CCR2CX3CR1)单核细胞募集。
Arterioscler Thromb Vasc Biol. 2017 Jul;37(7):1315-1322. doi: 10.1161/ATVBAHA.116.308925. Epub 2017 Apr 27.
4
Inhibition of dynamin prevents CCL2-mediated endocytosis of CCR2 and activation of ERK1/2.抑制动力蛋白可防止 CCL2 介导的 CCR2 内吞作用和 ERK1/2 的激活。
Cell Signal. 2009 Dec;21(12):1748-57. doi: 10.1016/j.cellsig.2009.07.010. Epub 2009 Jul 28.
5
TLR4 Signaling augments monocyte chemotaxis by regulating G protein-coupled receptor kinase 2 translocation.TLR4 信号通过调节 G 蛋白偶联受体激酶 2 的易位增强单核细胞趋化性。
J Immunol. 2013 Jul 15;191(2):857-64. doi: 10.4049/jimmunol.1300790. Epub 2013 Jun 14.
6
CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.CCL2/CCR2而非CCL5/CCR5介导骨关节炎中单核细胞募集、炎症及软骨破坏。
Ann Rheum Dis. 2017 May;76(5):914-922. doi: 10.1136/annrheumdis-2016-210426. Epub 2016 Dec 13.
7
High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.高密度脂蛋白在体外和体内抑制趋化因子和趋化因子受体。
Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1773-8. doi: 10.1161/ATVBAHA.110.211342. Epub 2010 Aug 11.
8
Hyperocclusion up-regulates CCL3 expression in CCL2- and CCR2-deficient mice.超咬合可上调 CCL2 和 CCR2 缺陷型小鼠中的 CCL3 表达。
J Dent Res. 2013 Jan;92(1):65-70. doi: 10.1177/0022034512467803. Epub 2012 Nov 9.
9
Targeting CCL2-CCR2 signaling pathway alleviates macrophage dysfunction in COPD via PI3K-AKT axis.靶向CCL2-CCR2信号通路通过PI3K-AKT轴减轻慢性阻塞性肺疾病中的巨噬细胞功能障碍。
Cell Commun Signal. 2024 Jul 17;22(1):364. doi: 10.1186/s12964-024-01746-z.
10
The chemokine receptor CCR2 mediates the binding and internalization of monocyte chemoattractant protein-1 along brain microvessels.趋化因子受体CCR2介导单核细胞趋化蛋白-1沿脑微血管的结合与内化。
J Neurosci. 2001 Dec 1;21(23):9214-23. doi: 10.1523/JNEUROSCI.21-23-09214.2001.

引用本文的文献

1
The role of the 3'-UTR of the chemokine receptor CCR2 and hnRNPA0 in regulating mRNA stability and subcellular distribution in human CD4 T cells.趋化因子受体CCR2的3'-非翻译区和hnRNPA0在调节人CD4 T细胞中mRNA稳定性及亚细胞分布方面的作用。
Front Immunol. 2025 Aug 20;16:1655273. doi: 10.3389/fimmu.2025.1655273. eCollection 2025.
2
Investigating the molecular mechanisms associated with ulcerative colitis through the application of single-cell combined spatial transcriptome sequencing.通过应用单细胞联合空间转录组测序来研究与溃疡性结肠炎相关的分子机制。
Front Immunol. 2025 May 13;16:1534768. doi: 10.3389/fimmu.2025.1534768. eCollection 2025.
3

本文引用的文献

1
Intrinsic bias at non-canonical, β-arrestin-coupled seven transmembrane receptors.非规范β-arrestin 偶联七跨膜受体的固有偏倚。
Mol Cell. 2021 Nov 18;81(22):4605-4621.e11. doi: 10.1016/j.molcel.2021.09.007. Epub 2021 Sep 27.
2
Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting.CCL2-CCR2 信号轴在癌症中的作用:机制与治疗靶点。
Cell Prolif. 2021 Oct;54(10):e13115. doi: 10.1111/cpr.13115. Epub 2021 Aug 31.
3
Genetic mechanisms of critical illness in COVID-19.新型冠状病毒肺炎危重症的遗传机制。
Combination treatment with anti-RANKL and antibiotics for preventing joint destruction in septic arthritis.
抗RANKL与抗生素联合治疗预防化脓性关节炎中的关节破坏。
JCI Insight. 2025 Mar 24;10(6):e184954. doi: 10.1172/jci.insight.184954.
4
Host FSTL1 defines the impact of stem cell therapy on liver fibrosis by potentiating the early recruitment of inflammatory macrophages.宿主FSTL1通过增强炎症巨噬细胞的早期募集来定义干细胞疗法对肝纤维化的影响。
Signal Transduct Target Ther. 2025 Mar 7;10(1):81. doi: 10.1038/s41392-025-02162-6.
5
Neurodegenerative diseases and neuroinflammation-induced apoptosis.神经退行性疾病与神经炎症诱导的细胞凋亡。
Open Life Sci. 2025 Feb 25;20(1):20221051. doi: 10.1515/biol-2022-1051. eCollection 2025.
6
Migration arrest and transendothelial trafficking of human pathogenic-like Th17 cells are mediated by differentially positioned chemokines.人致病性样Th17细胞的迁移停滞和跨内皮运输由不同定位的趋化因子介导。
Nat Commun. 2025 Feb 26;16(1):1978. doi: 10.1038/s41467-025-57002-6.
7
Origin, Function, and Implications of Intestinal and Hepatic Macrophages in the Pathogenesis of Alcohol-Associated Liver Disease.肠道和肝脏巨噬细胞在酒精性肝病发病机制中的起源、功能及意义
Cells. 2025 Jan 30;14(3):207. doi: 10.3390/cells14030207.
8
Quantitative Structure-Activity Relationship (QSAR) Modeling of Chiral CCR2 Antagonists with a Multidimensional Space of Novel Chirality Descriptors.基于新型手性描述符多维空间的手性CCR2拮抗剂定量构效关系(QSAR)建模
Molecules. 2025 Jan 14;30(2):307. doi: 10.3390/molecules30020307.
9
Gene function revealed at the moment of stochastic gene silencing.基因功能在随机基因沉默之时得以揭示。
Commun Biol. 2025 Jan 19;8(1):88. doi: 10.1038/s42003-025-07530-0.
10
Essential strategies for the detection of constitutive and ligand-dependent Gi-directed activity of 7TM receptors using bioluminescence resonance energy transfer.利用生物发光共振能量转移检测7跨膜受体组成型和配体依赖性Gi介导活性的基本策略。
bioRxiv. 2024 Dec 9:2024.12.04.626681. doi: 10.1101/2024.12.04.626681.
Nature. 2021 Mar;591(7848):92-98. doi: 10.1038/s41586-020-03065-y. Epub 2020 Dec 11.
4
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy.抑制CCL2受体CCR2可增强肿瘤对免疫检查点疗法的反应。
Commun Biol. 2020 Nov 27;3(1):720. doi: 10.1038/s42003-020-01441-y.
5
ACKR4 Recruits GRK3 Prior to β-Arrestins but Can Scavenge Chemokines in the Absence of β-Arrestins.ACKR4 在β-arrestins 之前募集 GRK3,但在没有β-arrestins 的情况下可以清除趋化因子。
Front Immunol. 2020 Apr 22;11:720. doi: 10.3389/fimmu.2020.00720. eCollection 2020.
6
A negative-feedback loop maintains optimal chemokine concentrations for directional cell migration.负反馈环维持趋化因子浓度以促进定向细胞迁移。
Nat Cell Biol. 2020 Mar;22(3):266-273. doi: 10.1038/s41556-020-0465-4. Epub 2020 Feb 10.
7
CCR2-Mediated Uptake of Constitutively Produced CCL2: A Mechanism for Regulating Chemokine Levels in the Blood.CCR2 介导的固有产生的 CCL2 的摄取:调节血液中趋化因子水平的机制。
J Immunol. 2019 Dec 15;203(12):3157-3165. doi: 10.4049/jimmunol.1900961. Epub 2019 Nov 1.
8
Variable G protein determinants of GPCR coupling selectivity.可变 G 蛋白决定 GPCR 偶联选择性。
Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):12054-12059. doi: 10.1073/pnas.1905993116. Epub 2019 May 29.
9
Potentials of C-C motif chemokine 2-C-C chemokine receptor type 2 blockers including propagermanium as anticancer agents.C-C 基序趋化因子 2-C-C 趋化因子受体 2 阻断剂(包括普罗加曼)作为抗癌剂的潜力。
Cancer Sci. 2019 Jul;110(7):2090-2099. doi: 10.1111/cas.14075. Epub 2019 Jun 10.
10
CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing.CHOPCHOP v3:扩展 CRISPR 网络工具包,超越基因组编辑。
Nucleic Acids Res. 2019 Jul 2;47(W1):W171-W174. doi: 10.1093/nar/gkz365.